Protopanaxadiol as a Dual-Action Therapeutic Agent: Enhancing Radiotherapy Efficacy and Mitigating DMBA-Induced Breast Cancer through Multi-Target Mechanisms. - Mahmoud AA; Abdelrhman IG; Hussein MA; Auf MA; Hamdy AM; Emara AA; Elsayed HA; Abuelkasem SS; El-Adl NI; Mosaad YO (Current pharmaceutical design, 2026)